Differential Effects of Trimipramine and Fluoxetine on Sleep
in Geriatric Depression

The effects of trimipramine, a tricyclic antidepressant (TCA) with atypical pharmacological properties, and fluoxetine, a selective serotonine reuptake inhibitor (SSRI), were compared in an exploratory analysis using mood and polysomnographic parameters during a six-week double-blind trial in 19 depressed geriatric patients. In sleep EEG measures, trimipramine demonstrated clear-cut effects on sleep measures resulting in higher values for sleep efficiency, total sleep time, stage 2 sleep, and shorter wake time. Under fluoxetine treatment, the proportion of REM sleep was decreased and REM latency was lengthened, whereas no change in REM sleep parameters was observed in the trimipramine group. The present data suggest that early antidepressant effects of medication occur independently of drug-induced changes in objective measures of sleep, i. e. suppression of REM sleep.

References

• 1 Armitage R, Yonkers K, Cole D, Rush A J. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.  J Clin Psychopharmacology. 1997;  17 161-168
• 2 Berger M, Gastpar M. Trimipramine: a challenge to current concepts on antidepressives.  Eur Arch Psychiatry Clin Neurosci. 1996;  246 235-239
• 3 Berger M, Riemann D. REM sleep in depression - an overview.  J Sleep Res. 1993;  2 211-223
• 4 Dunleavy D LF, Brezinova V, Oswald I, Maclean A W, Tinker M. Changes during weeks in effects of tricyclic drugs on the human sleeping brain.  Brit J Psychiatr. 1972;  120 663-672
• 5 Feinberg I, Koresko R L, Heller N. EEG sleep pattern as a function of normal and pathological aging in man.  J Psychiatr Res. 1967;  5 107-144
• 6 Gillin J C, Duncan W C, Murphy D L, Post R M, Wehr TA Goodwin F K, Wyatt R J, Bunney W E. Age related changes in depressed and normal subjects.  Psychiatry Res. 1981;  4 73-78
• 7 Gillin J C, Rapaport M, Erman M K, Winokur A, Albala B J. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.  J Clin Psychiatry. 1997;  58 185-192
• 8 Hamilton M. A rating scale for depression.  J Neurology, Neurosurgery and Psychiatry. 1960;  23 56-62
• 9 Helmchen H, Linden M. The differentiation between depression and dementia in the very old.  Ageing and society. 1993;  13 589-617
• 10 Hohagen F, Montero R F, Weiss E, Lis S, Schonbrunn E, Dressing H, Riemann D, Berger M. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics?.  Eur Arch Psychiatry & Clin Neurosci. 1994;  244 65-72
• 11 Khazan N, Brown P. Differential effects of three tricyclic antidepressants on sleep and REM sleep in the rat.  Life Sci. 1970;  9 279-284
• 12 Lauer C J, Riemann D, Wiegand M, Berger M. From early adulthood changes in EEG sleep of depressed patients and healthy volunteers.  Biol Psychiatry. 1991;  29 979-993
• 13 Miles L E, Dement W C. Sleep and aging.  Sleep. 1980;  3 119-121
• 14 Montgomery S A, Asberg M. A new depression scale designed to be sensitive to change.  Brit J Psychiatry. 1979;  134 382-389
• 15 Montgomery S A. The efficacy of fluoxetine as an antidepressant in the short and long term.  Int Clin Psychopharmacol. 1989;  4 (Suppl l) 113-119
• 16 Nicholson A N, Pascoe P A, Turner C. Modulation of sleep by trimipramine in man.  Europ J Clin Pharmacology. 1989;  37 145-150
• 17 Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington DC; National Institute of Health Publication 204, U.S. Government Printing Office 1968
• 18 Regier D A, Framer M E, Rae D S, et a l. et al . One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the epidiologic catchment area study.  Acta Psychiat Scand. 1993;  88 35-47
• 19 Reynolds C F, Kupfer D J, Taska D J, Hoch C C, Spiker D G, Sewitch D, Zimmer B, Marin R S, Nelson J P, Martin D, Morycz R. EEG sleep in elderly depressed, demented, and healthy subjects.  Biol Psychiatry. 1985;  20 431-442
• 20 Reynolds C F, Kupfer D J, Hoch C C, Houck P R, Stack J A, Berman S R, Campbell P I, Zimmer B. Sleep deprivation as a probe in the elderly.  Arch Gen Psychiatry,. 1987;  44 982-990
• 21 Riemann D, Hohagen F, Bahro M, Lis S, Stadtmüller G, Gann H, Berger M. Cholinergic neurotransmission, REM sleep and depression.  J Psychosomatic Res. 1994;  38 (Suppl 1) 15-25
• 22 Rüther E. Depression, circadian rhythms and trimipramine.  Drugs. 1989;  38 (Suppl 1) 1-3
• 23 Rush A J, Armitage R, Gillin J C, Yonkers K A, Winokur A, Moldofsky H, Vogel G W, Kaplita S B, Fleming J B, Montlaisir J, Erman M K, Albala B J, McQuade R D. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.  Biol Psychiatry. 1998;  44 3-14
• 24 Sonntag A, Rothe B, Guldner J, Yassouridis A, Holsboer F, Steiger A. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during drug treatment of major depression.  Depression. 1996;  4 1-13
• 25 Spiegel R. Sleep and sleeplessness in advanced age. Advances in sleep research. New York; Spectrum 1981 Vol. 5
• 26 Steiger A, von Bardeleben U, Guldner J, Lauer C, Rothe B, Holsboer F. The sleep EEG and nocturnal hormonal secretion studies on changes during the course of depression and on effects of CNS-active drugs.  Progress in Neuro-Psychopharmacology & Biological Psychiatry. 1993;  17 125-137
• 27 Thase M E. Depression, sleep, and antidepressants.  J Clin Psychiatry. 1998;  59 (Suppl 4) 55-65
• 28 Trivedi M H, Rush, AJ, Armitage R, Gullion C M, Grannemann B D, Orsulak P J, Roffwarg H P. Effects of fluoxetine on the polysomnogram in outpatients with major depression.  Neuropsychopharmacology. 1999;  20 447-459
• 29 Ulrich R F, Shaw D H, Kupfer D J. Effects of aging on EEG sleep in depression.  Sleep. 1980;  3 31-40
• 30 Von Zerssen D, Koeller D -M, Rey E -R. Die Befindlichkeits-Skala (Bf-S) - ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittsuntersuchungen.  Drug Res. 1970;  20 915-918
• 31 Vasar V, Appelberg B, Rimon R, Selvaratnam J. The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study of healthy volunteers.  Int Clin Psychopharmacol. 1994;  9 203-206
• 32 Ware J C, Brown PJ Moorad P J, Pittard J T, Cobart B. Effects on sleep: a double-blind study comparing imipramine to the sedating tricyclic antidepressant trimipramine to depressed insomniac patients.  Sleep. 1989;  12 537-549
• 33 Wasserman A, Khazan N. Effects of chronic treatment with imipramine, desipramine and trimipramine on REM sleep in the rat.  Pharmacologist. 1971;  13 255
• 34 Wiegand M, Berger M, Zulley J, von Zerssen D. The effect of trimipramine on sleep in patients with major depressive disorder.  Pharmacopsychiatry. 1986;  19 198-199
• 35 Wiegand M, Berger M. Action of trimipramine on sleep and pituitary hormone secretion.  Drugs. 1989;  38 35-42